After a mastectomy, the contour of the breasts is restore via a surgical process known as breast reconstruction. A mastectomy is necessary to treat or prevent breast cancer in a patient. Therefore, the market is anticipate to have excellent growth possibilities over the forecast period due to the rising occurrence of breast cancer worldwide. Additionally, the market will rise during the forecast period due to the rising demand for mastectomy-related rapid breast reconstruction treatments.

The market for breast reconstruction in 2021 was worth USD 2.68 billion, and it will be worth USD 4.98 billion by 2030, growing at a 7.11% CAGR during the forecast period.

Breast reconstruction surgery may involve body tissue reconstruction or implants to alter the breasts. Breast reduction, breast lift, and scar correction are further breast reconstruction procedures.

The market for breast reconstruction also has favorable growth potential throughout the projection period due to technical developments and businesses offering a variety of goods in the form of implants or mesh.

Market Dynamics

Drivers

After a mastectomy, many women choose to have breast reconstruction surgery. This is primarily due to the escalating worries and rising knowledge about the efficacy and safety of reconstructive procedures. Both industrialized and developing nations seeing increases in living standards can see this pattern. The global breast reconstruction market is anticipated to be driven by an increase in breast cancer prevalence. An increase in the number of breast reconstruction procedures, and a surge in demand for acellular dermal matrix. Breast reconstruction after a mastectomy is becoming more fashionable everywhere.

Restraints

One of the key factors limit the expansion of the market is the high cost. For each breast, breast reconstruction surgery typically costs between USD 25,000 and USD 50,000 and between USD 50,000 and USD 100,000 for both.

Opportunity 

Skin-sparing mastectomy is becoming more commonplace throughout the world, and it is almost at the point where it will become the standard of care for breast reconstruction. It will experience exponential growth in the near future.

Market Segmentation 

On the basis of type, the market is segment into saline implants, implants, silicone implants, and tissue expanders.

Implants generate more than 60% of overall revenue in 2021. As a result, more people have breast augmentation treatment that include breast implants. For instance, according to the NCBI, 8.08 out of every 1,000 American women currently get breast implants. Additionally, the University of Utah Health estimates that almost 35 million women have texture breast implants. 

On the basis of end-user, the market is segment into ambulatory surgical centers, hospitals, and cosmetology clinics. 

In 2021, the hospital segment led the market with the largest revenue share of more than 45%. The growth of hospitals around the world is responsible for the segment’s domination. For instance, 80% of India’s healthcare market is made up of hospitals. According to the Athar Institute of Health Management & Studies. In addition, there are 193 private hospitals and 706 public hospitals in Canada, according to The Canadian Encyclopedia. Globally, there has also been a rise in medical tourism.

Regional Analysis 

North America had the biggest revenue share in 2021. This is explain by the high incidence of breast cancer in this region. For instance, the Canadian Cancer Society reports that just 15 of the 78 Canadian women. Who are diagnose with breast cancer each day go on to die from the condition. In 2022, breast cancer will be diagnose in 28,600 Canadian women, a reliable source predicts. The expansion of businesses making acellular dermal matrices and breast implant.As as well as the persistent increase in the prevalence of breast cancer, all contribute to the market’s expansion in the area.

Key Players 

  • Sebbin
  • HANSBIOMED CO. LTD
  • KOKEN CO. LTD
  • Wanhe
  • DPS Technology Development Ltd
  • Integra Lifesciences
  • AirXpanders
  • Arion Laboratories
  • Establishment Labs S.A.
  • PMT Corporation
  • AbbVie Inc.
  • CEREPLAS
  • POLYTECH Health & Aesthetics GmbH
  • Ideal Implant incorporated 
  • GC Aesthetics
  • Sientra Inc.
  • Johnson & Johnson
  • Allergan Inc.
  • Mentor Worldwide LLC

The market for breast reconstruct in 2021 was worth USD 2.68 billion, and it will be worth USD 4.98 billion by 2030, growing at a 7.11% CAGR during the forecast period. The breast reconstruction market is expanding favorably due to several causes, including the rising incidence of breast cancer, the rise in aesthetic and reconstructive procedure, the rapid introduction of technologically sophisticate breast reconstruction products, and others. 

There has been an expansion in the quantity of bosom disease patients universally. For example, as per the WHO, around 2.3 million ladies worldwide were determined to have bosom malignant growth in the year 2020. Besides, according to a comparative source, starting around 2020, more than 7.8 million new bosom malignant growth cases were analyzed beginning around 2015. Moreover, according to Disease Exploration U.K., roughly 55,900 bosom malignant growth patients are analyzed yearly in the U.K. alone. Besides, as per a comparative source, bosom disease is the most well-known sort of malignant growth in the U.K.

Leave a Reply

Your email address will not be published. Required fields are marked *